Annals of Surgical Oncology Sign the Guestbook
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

10.1245/s10434-007-9520-7
Annals of Surgical Oncology 14:3392-3400 (2007)
© 2007 Society of Surgical Oncology
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by Strong, V. E.
Right arrow Articles by Brennan, M. F.
PubMed
Right arrow Articles by Strong, V. E.
Right arrow Articles by Brennan, M. F.

Original Article

Laparoscopic Adrenalectomy for Isolated Adrenal Metastasis

Vivian E. Strong, MD1, Michael D’Angelica, MD1, Laura Tang, MD2, Francesco Prete, MD1, Mithat Gönen, PhD3, Daniel Coit, MD1, Karim A. Touijer, MD1, Yuman Fong, MD1 and Murray F. Brennan, MD1

1 Department of Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
2 Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
3 Department of Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA

Correspondence: Address correspondence and reprint requests to: Vivian E. Strong, MD; E-mail: strongv{at}mskcc.org

Background: Use of laparoscopy for isolated adrenal metastases is controversial. The aims of this study were to characterize patients with isolated adrenal metastases; compare operative characteristics of the laparoscopic adrenalectomy (LA) versus open adrenalectomy (OA) approach; and compare long-term oncological and surgical outcomes.

Methods: Our adrenal resection database (1995–2006) identified 63 OA and 31 LA cases done for isolated adrenal metastases. Subset analysis was performed for all patients from isolated lung metastases (n = 39) and for all tumors smaller than 4.5 cm (n = 49).

Results: Overall, local recurrence was 17%, median survival 30 months and 5-year estimated survival 31%. The only independent predictor of survival for all (n = 94) was adrenal tumor size less than 4.5 cm (P = 0.01). When comparing LA with OA, no differences in local recurrence, margin status, disease-free interval or overall survival were observed for the entire group, or for patients with metastases only from lung cancer (n = 39) or for those with tumors smaller than 4.5 cm (n = 49). LA provided significantly shorter operative time (175 vs 208 min, P = 0.04), lower estimated blood loss (EBL) (106 vs 749 cc, P < 0.0001), shorter length of hospital stay (2.8 vs 8.0 days, P < 0.0001) and fewer total complications (P < 0.0001).

Conclusions: LA is equivalent to OA in terms of margin status, local recurrence, disease-free interval and overall survival. LA for metastatic adrenal lesions is safe, with equivalent long-term oncological outcomes providing the additional benefits of a minimally invasive technique. LA can be recommended as an appropriate initial approach for isolated adrenal metastases.

Key Words: Metastases • Minimally invasive surgery • Laparoscopic • Adrenalectomy




This article has been cited by other articles:


Home page
JCOHome page
T. Tanvetyanon, L. A. Robinson, M. J. Schell, V. E. Strong, R. Kapoor, D. G. Coit, and G. Bepler
Outcomes of Adrenalectomy for Isolated Synchronous Versus Metachronous Adrenal Metastases in Non-Small-Cell Lung Cancer: A Systematic Review and Pooled Analysis
J. Clin. Oncol., March 1, 2008; 26(7): 1142 - 1147.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the Society of Surgical Oncology.